Dear Health Care Professional Letter

Dear Health Care Professional Letter

Click Topic to Download File
INFORMATION ON THE RISKS OF VALPROATE USE IN FEMALE PATIENTS AND PREGNANT WOMEN
USE OF HYDROXYCHLOROQUINE (PLAQUENIL) IN THE CONTEXT OF COVID 19 - RISK OF QT PROLONGATION AND DRUG/DRUG INTERACTIONS
REPORTING MEDICAL ERRORS
SUSPECTED ORAL QUININE SULPHATE INDUCED BLEEDING AND INCOMPLETE ABORTION
SAFETY OF (DEXTRO)PROPOXYPHENE-CONTAINING PRODUCTS
REVIEW OF THE SAFETY OF METAMIZOLE SODIUM
REPORTING INCIDENTS OF THERAPEUTIC INEFFECTIVENESS AS ADVERSE EVENTS
PARACETAMOL AND THE RISK OF RARE BUT SERIOUS SKIN REACTIONS
OVER-THE-COUNTER COLD AND COUGH PREPARATIONS IN CHILDREN: FOLLOW-UP TO AN EARLIER COMMUNICATION
DICLOFENAC AND RISK OF CARDIOVASCULAR EVENTS (HEART ATTACK AND STROKE)
AZITHROMYCIN AND CARDIOVASCULAR RISKS
ANGIOTENSEN CONVERTING ENZYME INHIBITOR-ASSOCIATED ANGIODEMA
RARE OCCURRENCES OF A SERIOUS INFECTION OF THE GENITAL AREA WITH SODIUM-GLUCOSE COTRANSPORTER-2(SGLT2) INHIBITORS FOR DIABETES
HYDROCHLOROTHIAZIDE AND THE RISK OF SKIN CANCER
UPDATE-SAFETY INFORMATION ON VALSARTAN
SUSPENSION OF MARKETING AUTHORIZATION FOR CODEINE-CONTAINING COUGH SYRUPS
POTENTIAL FOR INCREASED LTR WITH CLARITHROMYCIN
RESTRICTIONS ON THE USE OF CODEINE AS AN ANALGESIC IN CHILDREN AND ADOLESCENTS
SAFETY OF INJECTABLE GADOLINIUM-BASED CONTRAST AGENTS USED IN MAGNETIC RESONANCE IMAGE (MRI) MACHINES
POTENTIAL CARCINOGENIC EFFECT OF GENTIAN VIOLET
POTENTIAL CONTAMINATION OF METFORMIN WITH N-NITROSODIMETHYLAMINE
SAFETY ALERT ON POTENTIAL CONTAMINATION OF RANITIDINE WITH N-NITROSODIMETHLAMINE
SEVERE BUT RARE LUNG INFLAMMATION WITH IBRANCE
RESTRICTIONS ON FLUOROQUINOLONE USE
RESTRICTIONS TO PREVENT THE USE OF VALPROATE MEDICINES IN WOMEN AND GIRLS OF CHILDBEARING POTENTIAL
RECALL OF AMLODIPIN/VALSATAN COMBINATION TABLETS
FOLLOW UP: SUSPENSION OF MARKET AUTHORISATION OF CODEINE-CONTAINING COUGH SYRUPS
SUSPENSION OF MARKETING AUTHORIZATION FOR ORAL KETOCONAZOLE PRODUCTS
UPDATE ON SAFETY OF PIOGLITAZONE
RARE BUT SERIOUS ALLERGIC REACTIONS WITH THE SKIN ANTISEPTIC CHLORHEXIDINE GLUCONATE
ORAL KETOCONAZOLE AND THE RISK OF SEVERE LIVER INJURY, ADRENAL GLAND PROBLEMS AND HARMFUL DRUG INTERACTIONS
ASSOCIATION OF IBANDRONIC ACID AND ANAPHYLAXIS (ANAPHYLACTIC REACTION, ANAPHYLACTIC SHOCK)
BOXED WARNING - EXJADE (DEFERASIROX)

THE FDA MISSION

The FDA exists to protect public health by assuring the safety, efficacy and security of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances, tobacco and the conduct of clinical trials in the country.

  • Discover More
  • Subscription Management Centre

    Connect & Get Interactive

  • Top